Asthma in the elderly

Aging Health

Volumn 6, Issue 3, 2010, Pages 301-317

  Antonelli Incalzi, Raffaele ^a,b   Corsonello, Andrea ^e   Pedone, Claudio ^a,c   Battaglia, Salvatore ^d   Bellia, Vincenzo ^d  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b Fondazione San Raffaele   (Italy)

^c Fondazione Alberto Sordi   (Italy)

^d UNIVERSITY OF PALERMO   (Italy)

^e NONE

Author keywords

Asthma; Elderly; Inhalers; Medication adherence; Multidimensional geriatric assessment

Indexed keywords

BAMBUTEROL; BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; FLUTICASONE; FORMOTEROL; IMMUNOGLOBULIN E; IPRATROPIUM BROMIDE; IPRATROPIUM BROMIDE PLUS SALBUTAMOL; OMALIZUMAB; OXITROPIUM BROMIDE; THEOPHYLLINE; TIOTROPIUM BROMIDE;

ADD ON THERAPY; AIR POLLUTION; ALLERGIC ASTHMA; ASTHMA; ATOPY; BRONCHODILATATION; BRONCHUS HYPERREACTIVITY; CANDIDIASIS; CATARACT; CIGARETTE SMOKING; CLINICAL FEATURE; COGNITIVE DEFECT; COMORBIDITY; CORTICOSTEROID INDUCED OSTEOPOROSIS; COUGHING; DIAGNOSTIC ERROR; DRUG BLOOD LEVEL; DRY POWDER; ELDERLY CARE; EPIDEMIOLOGICAL DATA; FORCED EXPIRATORY VOLUME; GASTROESOPHAGEAL REFLUX; GERIATRIC ASSESSMENT; HEALTH CARE ACCESS; HEALTH CARE NEED; HEART PALPITATION; HOARSENESS; HUMAN; INDIVIDUALIZATION; INHALER; INTRAOCULAR PRESSURE; METERED DOSE INHALER; NEBULIZER; OBESITY; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PATIENT MONITORING; PHYSICAL CAPACITY; POLYPHARMACY; POWDER INHALER; PRESCRIPTION; PREVALENCE; REVIEW; RISK FACTOR; SIDE EFFECT; TACHYCARDIA; TREATMENT OUTCOME; TREMOR; URINE RETENTION; XEROSTOMIA;

EID: 77953238325     PISSN: 1745509X     EISSN: 17455103     Source Type: Journal    
DOI: 10.2217/ahe.10.28     Document Type: Review

References (175)

1. Bellia V, Battaglia S, Catalano F et al.: Aging and disability affect misdiagnosis of COPD in elderly asthmatics: the SARA study. Chest 123(4), 1066-1072 (2003).
2. Banerjee DK, Lee GS, Malik SK, Daly S: Underdiagnosis of asthma in the elderly. Br. J. Dis. Chest 81(1), 23-29 (1987).
3. Enright PL, McClelland RL, Newman AB, Gottlieb DJ, Lebowitz MD: Underdiagnosis and undertreatment of asthma in the elderly. Cardiovascular Health Study Research Group. Chest 116(3), 603-613 (1999).
4. Parameswaran K, Hildreth AJ, Chadha D, Keaney NP, Taylor IK, Bansal SK: Asthma in the elderly: underperceived, underdiagnosed and undertreated; a community survey. Respir. Med. 92(3), 573-577 (1998).
5. Adams RJ, Wilson DH, Appleton S et al.: Underdiagnosed asthma in South Australia. Thorax 58(10), 846-850 (2003).
6. Chotirmall SH, Watts M, Branagan P, Donegan CF, Moore A, McElvaney NG: Diagnosis and management of asthma in older adults. J. Am. Geriatr. Soc. 57(5), 901-909 (2009).
7. Braman SS, Hanania NA: Asthma in older adults. Clin. Chest Med. 28(4), 685-702 (2007).
8. Bellia V, Catalano F, Scichilone N et al.: Sleep disorders in the elderly with and without chronic airflow obstruction: the SARA study. Sleep 26(3), 318-323 (2003).
9. Incalzi RA, Bellia V, Catalano F et al.: Evaluation of health outcomes in elderly patients with asthma and COPD using disease-specific and generic instruments: the Salute Respiratoria nell'Anziano (Sa.R.A.) Study. Chest 120(3), 734-742 (2001).
10. Leander M, Cronqvist A, Janson C, Uddenfeldt M, Rask-Andersen A: Non-respiratory symptoms and well-being in asthmatics from a general population sample. J. Asthma 46(6), 552-559 (2009).
11. Ichinose M: Differences of inflammatory mechanisms in asthma and COPD. Allergol. Int. 58(3), 307-313 (2009).
12. Hoshino T, Toda R, Aizawa H: Pharmacological treatment in asthma and COPD. Allergol. Int. 58(3), 341-346 (2009).
13. Ikaheimo P, Hartikainen S, Tuuponen T, Kiuttu J, Klaukka T: Comorbidity and medication load in adult asthmatics. Scand. J. Prim. Health Care 23(2), 88-94 (2005).
14. Diette GB, Krishnan JA, Dominici F et al.: Asthma in older patients: factors associated with hospitalization. Arch. Intern. Med. 162(10), 1123-1132 (2002).
15. Lesman-Leegte I, Jaarsma T, Coyne JC, Hillege HL, Van Veldhuisen DJ, Sanderman R: Quality of life and depressive symptoms in the elderly: a comparison between patients with heart failure and age-and gender-matched community controls. J. Card. Fail. 15(1), 17-23 (2009).
16. Banasiak W, Pociupany R, Wilkins A, Ponikowski P: Characteristics of patients with coronary artery disease managed on an outpatient basis in the population of Poland. Results of the multicentre RECENT trial. Kardiol. Pol. 65(2), 132-140; discussion 141-1132 (2007).
17. Bongers FJ, Schellevis FG, Bakx C, van den Bosch WJ, van der Zee J: Treatment of heart failure in Dutch general practice. BMC Fam. Pract. 7, 40 (2006).
18. Singh JA: Effect of comorbidity on quality of life of male veterans with prevalent primary total knee arthroplasty. Clin. Rheumatol. 28(9), 1083-1089 (2009).
19. Caughey GE, Vitry AI, Gilbert AL, Roughead EE: Prevalence of comorbidity of chronic diseases in Australia. BMC Public Health 8, 221 (2008).
20. Burr ML, Charles TJ, Roy K, Seaton A: Asthma in the elderly: an epidemiological survey. BMJ 1(6170), 1041-1044 (1979).
21. Dickinson JA, Meaker M, Searle M, Ratcliffe G: Screening older patients for obstructive airways disease in a semi-rural practice. Thorax 54(6), 501-505 (1999).
22. Soriano JB, Kiri VA, Maier WC, Strachan D: Increasing prevalence of asthma in UK primary care during the 1990s. Int. J. Tuberc. Lung Dis. 7(5), 415-421 (2003).
23. Lange P, Ulrik CS, Vestbo J: Mortality in adults with self-reported asthma. Copenhagen City Heart Study Group. Lancet 347(9011), 1285-1289 (1996).
24. Saks K, Kolk H, Allev R et al.: Health status of the older population in Estonia. Croat. Med. J. 42(6), 663-668 (2001).
25. Dantzer C, Tessier JF, Nejjari C, Barberger-Gateau P, Dartigues JF: Mortality of elderly subjects with self-reported asthma in a French cohort, 1991-1996. Eur. J. Epidemiol. 17(1), 57-63 (2001).
26. Hamzacebi H, Unsal M, Kayhan S, Bilgin S, Ercan S: Prevalence of asthma and respiratory symptoms by age, gender and smoking behaviour in Samsun, North Anatolia Turkey. Tuberk. Toraks. 54(4), 322-329 (2006).
27. Kotaniemi JT, Lundback B, Nieminen MM, Sovijarvi AR, Laitinen LA: Increase of asthma in adults in northern Finland? - a report from the FinEsS study. Allergy 56(2), 169-174 (2001).
28. Nejjari C, Tessier JF, Letenneur L, Dartigues JF, Barberger-Gateau P, Salamon R: Prevalence of self-reported asthma symptoms in a French elderly sample. Respir. Med. 90(7), 401-408 (1996).
29. Viegi G, Pedreschi M, Baldacci S et al.: Prevalence rates of respiratory symptoms and diseases in general population samples of North and Central Italy. Int. J. Tuberc. Lung Dis. 3(11), 1034-1042 (1999).
30. Arif AA, Rohrer JE, Delclos GL: A population-based study of asthma, quality of life, and occupation among elderly Hispanic and non-Hispanic whites: a cross-sectional investigation. BMC Public Health 5, 97 (2005).
31. Arif AA, Delclos GL, Lee ES, Tortolero SR, Whitehead LW: Prevalence and risk factors of asthma and wheezing among US adults: an analysis of the NHANES III data. Eur. Respir. J. 21(5), 827-833 (2003).
32. Burrows B, Barbee RA, Cline MG, Knudson RJ, Lebowitz MD: Characteristics of asthma among elderly adults in a sample of the general population. Chest 100(4), 935-942 (1991).
33. Bauer BA, Reed CE, Yunginger JW, Wollan PC, Silverstein MD: Incidence and outcomes of asthma in the elderly. A population-based study in Rochester, Minnesota. Chest 111(2), 303-310 (1997).
34. Peat JK, Woolcock AJ, Cullen K: Rate of decline of lung function in subjects with asthma. Eur. J. Respir. Dis. 70(3), 171-179 (1987).
35. Fletcher C, Peto R: The natural history of chronic airflow obstruction. BMJ 1(6077), 1645-1648 (1977).
36. Bellia V, Pedone C, Catalano F et al.: Asthma in the elderly: mortality rate and associated risk factors for mortality. Chest 132(4), 1175-1182 (2007).
37. Verbeken EK, Cauberghs M, Mertens I, Clement J, Lauweryns JM, Van de Woestijne KP: The senile lung. Comparison with normal and emphysematous lungs. 2. Functional aspects. Chest 101(3), 800-809 (1992).
38. Verbeken EK, Cauberghs M, Mertens I, Clement J, Lauweryns JM, Van de Woestijne KP: The senile lung. Comparison with normal and emphysematous lungs. 1. Structural aspects. Chest 101(3), 793-799 (1992).
39. Choy DK, Hui DS, Li ST et al.: Prevalence of wheeze, bronchial hyper-responsiveness and asthma in the elderly Chinese. Clin. Exp. Allergy 32(5), 702-707 (2002).
40. Horsley JR, Sterling IJ, Waters WE, Howell JB: How common is increased airway reactivity amongst the elderly? Gerontology 39(1), 38-48 (1993).
41. Hopp RJ, Bewtra A, Nair NM, Townley RG: The effect of age on methacholine response. J. Allergy Clin. Immunol. 76(4), 609-613 (1985).
42. Sparrow D, O'Connor GT, Rosner B, Segal MR, Weiss ST: The influence of age and level of pulmonary function on nonspecific airway responsiveness. The Normative Aging Study. Am. Rev. Respir. Dis. 143(5 Pt 1), 978-982 (1991).
43. Sparrow D, O'Connor GT, Rosner B, Weiss ST: Predictors of longitudinal change in methacholine airway responsiveness among middle-aged and older men: the Normative Aging Study. Am. J. Respir. Crit. Care Med. 149(2 Pt 1), 376-381 (1994).
44. Xu X, Niu T, Chen C et al.: Association of airway responsiveness with asthma and persistent wheeze in a Chinese population. Chest 119(3), 691-700 (2001).
45. Scichilone N, Messina M, Battaglia S, Catalano F, Bellia V: Airway hyperresponsiveness in the elderly: prevalence and clinical implications. Eur. Respir. J. 25(2), 364-375 (2005).
46. Lange P, Parner J, Vestbo J, Schnohr P, Jensen G: A 15-year follow-up study of ventilatory function in adults with asthma. N. Engl. J. Med. 339(17), 1194-1200 (1998).
47. Laprise C, Boulet LP: Asymptomatic airway hyperresponsiveness: a three-year follow-up. Am. J. Respir. Crit. Care Med. 156(2 Pt 1), 403-409 (1997).
48. O'Connor GT, Sparrow D, Weiss ST: A prospective longitudinal study of methacholine airway responsiveness as a predictor of pulmonary-function decline: the Normative Aging Study. Am. J. Respir. Crit. Care Med. 152(1), 87-92 (1995).
49. Parker DR, O'Connor GT, Sparrow D, Segal MR, Weiss ST: The relationship of nonspecific airway responsiveness and atopy to the rate of decline of lung function. The Normative Aging Study. Am. Rev. Respir. Dis. 141(3), 589-594 (1990).
50. Cabanes LR, Weber SN, Matran R et al.: Bronchial hyperresponsiveness to methacholine in patients with impaired left ventricular function. N. Engl. J. Med. 320(20), 1317-1322 (1989).
51. Law M, Morris JK, Wald N, Luczynska C, Burney P: Changes in atopy over a quarter of a century, based on cross sectional data at three time periods. BMJ 330(7501), 1187-1188 (2005).
52. Linneberg A, Gislum M, Johansen N, Husemoen LL, Jorgensen T: Temporal trends of aeroallergen sensitization over twenty-five years. Clin. Exp. Allergy 37(8), 1137-1142 (2007).
53. Ariano R, Panzani RC, Augeri G: Late onset asthma clinical and immunological data: importance of allergy. J. Investig. Allergol. Clin. Immunol. 8(1), 35-41 (1998).
54. Huss K, Naumann PL, Mason PJ et al.: Asthma severity, atopic status, allergen exposure and quality of life in elderly persons. Ann. Allergy Asthma Immunol. 86(5), 524-530 (2001).
55. Asero R: Birch and ragweed pollinosis north of Milan: a model to investigate the effects of exposure to 'new' airborne allergens. Allergy 57(11), 1063-1066 (2002).
56. Litonjua AA, Sparrow D, Weiss ST, O'Connor GT, Long AA, Ohman JL Jr: Sensitization to cat allergen is associated with asthma in older men and predicts new-onset airway hyperresponsiveness. The Normative Aging Study. Am. J. Respir. Crit. Care Med. 156(1), 23-27 (1997).
57. Parameswaran K, Hildreth AJ, Taylor IK, Keaney NP, Bansal SK: Predictors of asthma severity in the elderly: results of a community survey in Northeast England. J. Asthma 36(7), 613-618 (1999).
58. Liu T, Valdez R, Yoon PW, Crocker D, Moonesinghe R, Khoury MJ: The association between family history of asthma and the prevalence of asthma among US adults: National Health and Nutrition Examination Survey, 1999-2004. Genet. Med. 11(5), 323-328 (2009).
59. Zureik M, Orehek J: Diagnosis and severity of asthma in the elderly: results of a large survey in 1,485 asthmatics recruited by lung specialists. Respiration, 69(3), 223-228 (2002).
60. Eisner MD, Yelin EH, Trupin L, Blanc PD: Asthma and smoking status in a population-based study of California adults. Public Health Rep. 116(2), 148-157 (2001).
61. Silva GE, Sherrill DL, Guerra S, Barbee RA: Asthma as a risk factor for COPD in a longitudinal study. Chest 126(1), 59-65 (2004).
62. Tsuda Y, Noguchi T, Mochizuki H et al.: Patients with mild-to-moderate asthma may develop clinically significant chronic obstructive pulmonary disease. Respirology 14(4), 529-536 (2009).
63. James AL, Palmer LJ, Kicic E et al.: Decline in lung function in the Busselton Health Study: the effects of asthma and cigarette smoking. Am. J. Respir. Crit. Care Med. 171(2), 109-114 (2005).
64. Sherrill D, Guerra S, Bobadilla A, Barbee R: The role of concomitant respiratory diseases on the rate of decline in FEV1 among adult asthmatics. Eur. Respir. J. 21(1), 95-100 (2003).
65. Litonjua AA, Sparrow D, Celedon JC, DeMolles D, Weiss ST: Association of body mass index with the development of methacholine airway hyperresponsiveness in men: the Normative Aging Study. Thorax 57(7), 581-585 (2002).
66. Von Behren J, Lipsett M, Horn-Ross PL et al.: Obesity, waist size and prevalence of current asthma in the California Teachers Study cohort. Thorax 64(10), 889-893 (2009).
67. Eder W, Ege MJ, von Mutius E: The asthma epidemic. N. Engl. J. Med. 355(21), 2226-2235 (2006).
68. Beuther DA, Sutherland ER: Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am. J. Respir. Crit. Care Med. 175(7), 661-666 (2007).
69. Guerra S, Sherrill DL, Bobadilla A, Martinez FD, Barbee RA: The relation of body mass index to asthma, chronic bronchitis, and emphysema. Chest 122(4), 1256-1263 (2002).
70. Peters-Golden M, Swern A, Bird SS, Hustad CM, Grant E, Edelman JM: Influence of body mass index on the response to asthma controller agents. Eur. Respir. J. 27(3), 495-503 (2006).
71. Beuther DA, Weiss ST, Sutherland ER: Obesity and asthma. Am. J. Respir. Crit. Care Med. 174(2), 112-119 (2006).
72. Jang AS, Kim TH, Park JS et al.: Association of serum leptin and adiponectin with obesity in asthmatics. J. Asthma 46(1), 59-63 (2009).
73. Shore SA, Fredberg JJ: Obesity, smooth muscle, and airway hyperresponsiveness. J. Allergy Clin. Immunol. 115(5), 925-927 (2005).
74. Harding SM, Richter JE: The role of gastroesophageal reflux in chronic cough and asthma. Chest 111(5), 1389-1402 (1997).
75. Ruigomez A, Rodriguez LA, Wallander MA, Johansson S, Thomas M, Price D: Gastroesophageal reflux disease and asthma: a longitudinal study in UK general practice. Chest 128(1), 85-93 (2005).
76. Harding SM: Gastroesophageal reflux: a potential asthma trigger. Immunol. Allergy Clin. North Am. 25(1), 131-148 (2005).
77. Mold JW, Reed LE, Davis AB, Allen ML, Decktor DL, Robinson M: Prevalence of gastroesophageal reflux in elderly patients in a primary care setting. Am. J. Gastroenterol. 86(8), 965-970 (1991).
78. Koren HS: Associations between criteria air pollutants and asthma. Environ. Health Perspect. 103(Suppl. 6), 235-242 (1995).
79. Sheppard D, Wong WS, Uehara CF, Nadel JA, Boushey HA: Lower threshold and greater bronchomotor responsiveness of asthmatic subjects to sulfur dioxide. Am. Rev. Respir. Dis. 122(6), 873-878 (1980).
80. Mazumdar S, Schimmel H, Higgins IT: Relation of daily mortality to air pollution: an analysis of 14 London winters, 1958/59-1971/72. Arch. Environ. Health 37(4), 213-220 (1982).
81. Schwartz J, Marcus A: Mortality and air pollution in London: a time series analysis. Am. J. Epidemiol. 131(1), 185-194 (1990).
82. Pope CA III: Respiratory hospital admissions associated with PM10 pollution in Utah, Salt Lake, and Cache Valleys. Arch. Environ. Health 46(2), 90-97 (1991).
83. Bates DV, Sizto R: Air pollution and hospital admissions in Southern Ontario: the acid summer haze effect. Environ. Res. 43(2), 317-331 (1987).
84. Anees W, Moore VC, Burge PS: FEV1 decline in occupational asthma. Thorax 61(9), 751-755 (2006).
85. Saetta M, Turato G: Airway pathology in asthma. Eur. Respir. J. Suppl. 34, 18s-23s (2001).
86. Fahy JV, Kim KW, Liu J, Boushey HA: Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J. Allergy Clin. Immunol. 95(4), 843-852 (1995).
87. Mathur SK, Schwantes EA, Jarjour NN, Busse WW: Age-related changes in eosinophil function in human subjects. Chest 133(2), 412-419 (2008).
88. Busse PJ, Zhang TF, Srivastava K, Schofield B, Li XM: Effect of ageing on pulmonary inflammation, airway hyperresponsiveness and T and B cell responses in antigen-sensitized and -challenged mice. Clin. Exp. Allergy 37(9), 1392-1403 (2007).
89. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM: Asthma. From bronchoconstriction to airways inflammation and remodeling. Am. J. Respir. Crit. Care Med. 161(5), 1720-1745 (2000).
90. Roche WR, Beasley R, Williams JH, Holgate ST: Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1(8637), 520-524 (1989).
91. Carroll N, Elliot J, Morton A, James A: The structure of large and small airways in nonfatal and fatal asthma. Am. Rev. Respir. Dis. 147(2), 405-410 (1993).
92. Saglani S, Molyneux C, Gong H et al.: Ultrastructure of the reticular basement membrane in asthmatic adults, children and infants. Eur. Respir. J. 28(3), 505-512 (2006).
93. Sobonya RE: Quantitative structural alterations in long-standing allergic asthma. Am. Rev. Respir. Dis. 130(2), 289-292 (1984).
94. Payne DN, Rogers AV, Adelroth E et al.: Early thickening of the reticular basement membrane in children with difficult asthma. Am. J. Respir. Crit. Care Med. 167(1), 78-82 (2003).
95. Bai TR, Cooper J, Koelmeyer T, Pare PD, Weir TD: The effect of age and duration of disease on airway structure in fatal asthma. Am. J. Respir. Crit. Care Med. 162(2 Pt 1), 663-669 (2000).
96. Vignola AM, Bonanno A, Profita M et al.: Effect of age and asthma duration upon elastase and a1-antitrypsin levels in adult asthmatics. Eur. Respir. J. 22(5), 795-801 (2003).
97. Cassino C, Berger KI, Goldring RM et al.: Duration of asthma and physiologic outcomes in elderly nonsmokers. Am. J. Respir. Crit. Care Med. 162(4 Pt 1), 1423-1428 (2000).
98. Braman SS, Kaemmerlen JT, Davis SM: Asthma in the elderly. A comparison between patients with recently acquired and long-standing disease. Am. Rev. Respir. Dis. 143(2), 336-340 (1991).
99. Bellia V, Cibella F, Cuttitta G et al.: Effect of age upon airway obstruction and reversibility in adult patients with asthma. Chest 114(5), 1336-1342 (1998).
100. Fabbri LM, Romagnoli M, Corbetta L et al.: Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 167(3), 418-424 (2003).
101. Di Lorenzo G, Mansueto P, Ditta V et al.: Similarity and differences in elderly patients with fixed airflow obstruction by asthma and by chronic obstructive pulmonary disease. Respir. Med. 102(2), 232-238 (2008).
102. Permutt S, Martin HB: Static pressure-volume characteristics of lungs in normal males. J. Appl. Physiol. 15, 819-825 (1960).
103. Janssens JP, Pache JC, Nicod LP: Physiological changes in respiratory function associated with ageing. Eur. Respir. J. 13(1), 197-205 (1999).
104. Ding DJ, Martin JG, Macklem PT: Effects of lung volume on maximal methacholine-induced bronchoconstriction in normal humans. J. Appl. Physiol. 62(3), 1324-1330 (1987).
105. Scichilone N, Marchese R, Catalano F, Togias A, Vignola AM, Bellia V: The bronchodilatory effect of deep inspiration diminishes with aging. Respir. Med. 98(9), 838-843 (2004). (Pubitemid 39069332)
106. Enright PL, Kronmal RA, Manolio TA, Schenker MB, Hyatt RE: Respiratory muscle strength in the elderly. Correlates and reference values. Cardiovascular Health Study Research Group. Am. J. Respir. Crit. Care Med. 149(2 Pt 1), 430-438 (1994).
107. Bellia V, Pistelli R, Catalano F et al.: Quality control of spirometry in the elderly. The SA.R.A. study. SAlute Respiration nell'Anziano = Respiratory Health in the Elderly. Am. J. Respir. Crit. Care Med. 161(4 Pt 1), 1094-1100 (2000).
108. Lehmann S, Vollset SE, Nygaard HA, Gulsvik A: Factors determining performance of bronchodilator reversibility tests in middle-aged and elderly. Respir. Med. 98(11), 1071-1079 (2004).
109. Connolly MJ, Crowley JJ, Charan NB, Nielson CP, Vestal RE: Impaired bronchodilator response to albuterol in healthy elderly men and women. Chest 108(2), 401-406 (1995).
110. Kizkin O, Turker G, Hacievliyagil SS, Gunen H: Asthma, age, and early reversibility testing. J. Asthma 40(3), 317-321 (2003).
111. King MJ, Hanania NA: Asthma in the elderly: current knowledge and future directions. Curr. Opin. Pulm. Med. 16(1), 55-59 (2010).
112. Pitta F, Troosters T, Probst VS, Spruit MA, Decramer M, Gosselink R: Quantifying physical activity in daily life with questionnaires and motion sensors in COPD. Eur. Respir. J. 27(5), 1040-1055 (2006).
113. Connolly MJ, Crowley JJ, Charan NB, Nielson CP, Vestal RE: Reduced subjective awareness of bronchoconstriction provoked by methacholine in elderly asthmatic and normal subjects as measured on a simple awareness scale. Thorax 47(6), 410-413 (1992).
114. Cuttitta G, Cibella F, Bellia V et al.: Changes in FVC during methacholine-induced bronchoconstriction in elderly patients with asthma: bronchial hyperresponsiveness and aging. Chest 119(6), 1685-1690 (2001).
115. Ekici M, Apan A, Ekici A, Erdemoglu AK: Perception of bronchoconstriction in elderly asthmatics. J. Asthma 38(8), 691-696 (2001).
116. Bellia V, Pistelli R, Filippazzo G et al.: Prevalence of nocturnal asthma in a general population sample: determinants and effect of aging. J. Asthma 37(7), 595-602 (2000).
117. Battaglia S, Sandrini MC, Catalano F et al.: Effects of aging on sensation of dyspnea and health-related quality of life in elderly asthmatics. Aging Clin. Exp. Res. 17(4), 287-292 (2005).
118. Leite Ribeiro TE, Costa de Freitas Silva E, Silveira de Meneses SL, Lopes AJ: Correlation of clinical findings with functional parameters in elderly asthma patients. Rev. Port. Pneumol. 15(6), 1029-1041 (2009).
119. Wijnhoven HA, Kriegsman DM, Hesselink AE, de Haan M, Schellevis FG: The influence of co-morbidity on health-related quality of life in asthma and COPD patients. Respir. Med. 97(5), 468-475 (2003). (Pubitemid 36519517)
120. Ebihara S, Saito H, Kanda A et al.: Impaired efficacy of cough in patients with Parkinson disease. Chest 124(3), 1009-1015 (2003).
121. Urso DL: Asthma in the elderly. Curr. Gerontol. Geriatr. Res. 858415 (2009).
122. Raj AA, Birring SS, Green R, Grant A, de Caestecker J, Pavord ID: Prevalence of inflammatory bowel disease in patients with airways disease. Respir. Med. 102(5), 780-785 (2008).
123. Kim HY, So YK, Dhong HJ et al.: Prevalence of lower airway diseases in patients with chronic rhinosinusitis. Acta Otolaryngol. Suppl. (558), 110-114 (2007).
124. Oguzulgen IK, Kervan F, Ozis T, Turktas H: The impact of bronchiectasis in clinical presentation of asthma. South Med. J. 100(5), 468-471 (2007).
125. Weiner P, Magadle R, Waizman J, Weiner M, Rabner M, Zamir D: Characteristics of asthma in the elderly. Eur. Respir. J. 12(3), 564-568 (1998).
126. Hizawa N, Yamaguchi E, Konno S, Tanino Y, Jinushi E, Nishimura M: A functional polymorphism in the RANTES gene promoter is associated with the development of late-onset asthma. Am. J. Respir. Crit. Care Med. 166(5), 686-690 (2002).
127. Moore WC, Meyers DA, Wenzel SE et al.: Identification of Asthma Phenotypes using Cluster Analysis in the Severe Asthma Research Program. Am. J. Respir. Crit. Care Med. (2009).
128. Strunk RC, Bloomberg GR: Omalizumab for asthma. N. Engl. J. Med. 354(25), 2689-2695 (2006).
129. Maykut RJ, Kianifard F, Geba GP: Response of older patients with IgE-mediated asthma to omalizumab: a pooled analysis. J. Asthma 45(3), 173-181 (2008).
130. Hindle M, Newton DA, Chrystyn H: Dry powder inhalers are bioequivalent to metered-dose inhalers. A study using a new urinary albuterol (salbutamol) assay technique. Chest 107(3), 629-633 (1995).
131. Allen SC: Competence thresholds for the use of inhalers in people with dementia. Age Ageing 26(2), 83-86 (1997).
132. Allen S: Are inhaled systemic therapies a viable option for the treatment of the elderly patient? Drugs Aging 25(2), 89-94 (2008).
133. Chan HK: Dry powder aerosol delivery systems: current and future research directions. J. Aerosol Med. 19(1), 21-27 (2006).
134. Rau JL: Practical problems with aerosol therapy in COPD. Respir. Care 51(2), 158-172 (2006).
135. Yokoyama H, Yamamura Y, Ozeki T, Iga T, Yamada Y: Analysis of relationship between peak inspiratory flow rate and amount of drug delivered to lungs following inhalation of fluticasone propionate with a Diskhaler. Biol. Pharm. Bull. 30(1), 162-164 (2007).
136. Borgstrom L, Olsson B, Thorsson L: Degree of throat deposition can explain the variability in lung deposition of inhaled drugs. J. Aerosol Med. 19(4), 473-483 (2006).
137. Sakagami M: In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery. Adv. Drug Deliv. Rev. 58(9-10), 1030-1060 (2006).
138. Allen SC, Prior A: What determines whether an elderly patient can use a metered dose inhaler correctly? Br. J. Dis. Chest 80(1), 45-49 (1986).
139. Dow L, Fowler L, Lamb H: Elderly people's technique in using dry powder inhalers. New inhaler devices are rarely used by older people in the community. BMJ 323(7303), 49-50 (2001).
140. Allen SC, Ragab S: Ability to learn inhaler technique in relation to cognitive scores and tests of praxis in old age. Postgrad. Med. J. 78(915), 37-39 (2002).
141. Diggory P, Fernandez C, Humphrey A, Jones V, Murphy M: Comparison of elderly people's technique in using two dry powder inhalers to deliver zanamivir: randomised controlled trial. BMJ 322(7286), 577-579 (2001).
142. Allen SC, Jain M, Ragab S, Malik N: Acquisition and short-term retention of inhaler techniques require intact executive function in elderly subjects. Age Ageing 32(3), 299-302 (2003).
143. Board M, Allen SC: A simple drawing test to identify patients who are unlikely to be able to learn to use an inhaler. Int. J. Clin. Pract. 60(5), 510-513 (2006).
144. Connolly MJ: Inhaler technique of elderly patients: comparison of metered-dose inhalers and large volume spacer devices. Age Ageing 24(3), 190-192 (1995).
145. Ho SF, MS OM, Steward JA, Breay P, Burr ML: Inhaler technique in older people in the community. Age Ageing 33(2), 185-188 (2004).
146. Newnham DM: Asthma medications and their potential adverse effects in the elderly: recommendations for prescribing. Drug Saf. 24(14), 1065-1080 (2001).
147. Veehof LJ, Stewart RE, Meyboom-de Jong B, Haaijer-Ruskamp FM: Adverse drug reactions and polypharmacy in the elderly in general practice. Eur. J. Clin. Pharmacol. 55(7), 533-536 (1999).
148. van Zyl AI, Jennings AA, Bateman ED, Opie LH: Comparison of respiratory effects of two cardioselective b-blockers, celiprolol and atenolol, in asthmatics with mild to moderate hypertension. Chest 95(1), 209-213 (1989).
149. Salpeter S, Ormiston T, Salpeter E: Cardioselective b-blockers for reversible airway disease. Cochrane Database Syst. Rev. (1), CD002992 (2002).
150. Hartert TV, Togias A, Mellen BG, Mitchel EF, Snowden MS, Griffin MR: Underutilization of controller and rescue medications among older adults with asthma requiring hospital care. J. Am. Geriatr. Soc. 48(6), 651-657 (2000).
151. Sin DD, Tu JV: Inhaled corticosteroid therapy reduces the risk of rehospitalization and all-cause mortality in elderly asthmatics. Eur. Respir. J. 17(3), 380-385 (2001).
152. Slavin RG, Haselkorn T, Lee JH, Zheng B, Deniz Y, Wenzel SE: Asthma in older adults: observations from the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) study. Ann. Allergy Asthma Immunol. 96(3), 406-414 (2006).
153. Forsell M, Sjogren P, Johansson O: Need of assistance with daily oral hygiene measures among nursing home resident elderly versus the actual assistance received from the staff. Open Dent. J. 3, 241-244 (2009).
154. Katsura H, Kida K: A comparison of bone mineral density in elderly female patients with COPD and bronchial asthma. Chest 122(6), 1949-1955 (2002).
155. Laatikainen AK, Kroger HP, Tukiainen HO, Honkanen RJ, Saarikoski SV: Bone mineral density in perimenopausal women with asthma: a population-based cross-sectional study. Am. J. Respir. Crit. Care Med. 159(4 Pt 1), 1179-1185 (1999).
156. Toogood JH: Side effects of inhaled corticosteroids. J. Allergy Clin. Immunol. 102(5), 705-713 (1998).
157. Ip M, Lam K, Yam L, Kung A, Ng M: Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids. Chest 105(6), 1722-1727 (1994).
158. Israel E, Banerjee TR, Fitzmaurice GM, Kotlov TV, LaHive K, LeBoff MS: Effects of inhaled glucocorticoids on bone density in premenopausal women. N. Engl. J. Med. 345(13), 941-947 (2001).
159. Jones A, Fay JK, Burr M, Stone M, Hood K, Roberts G: Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. (1), CD003537 (2002).
160. Walsh LJ, Wong CA, Oborne J et al.: Adverse effects of oral corticosteroids in relation to dose in patients with lung disease. Thorax 56(4), 279-284 (2001).
161. Bellia V, Battaglia S, Matera MG, Cazzola M: The use of bronchodilators in the treatment of airway obstruction in elderly patients. Pulm. Pharmacol. Ther. 19(5), 311-319 (2006).
162. Connolly MJ, Crowley JJ, Nielson CP, Charan NB, Vestal RE: Peripheral mononuclear leucocyte b adrenoceptors and non-specific bronchial responsiveness to methacholine in young and elderly normal subjects and asthmatic patients. Thorax 49(1), 26-32 (1994).
163. Ullah MI, Newman GB, Saunders KB: Influence of age on response to ipratropium and salbutamol in asthma. Thorax 36(7), 523-529 (1981).
164. Calverley PM, Anderson JA, Celli B et al.: Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N. Engl. J. Med. 356(8), 775-789 (2007).
165. Sitar DS, Aoki FY, Warren CP et al.: A placebo-controlled dose-finding study with bambuterol in elderly patients with asthma. Chest 103(3), 771-776 (1993).
166. Thomson NC, Angus R, Quebe-Fehling E, Brambilla R: Efficacy and tolerability of formoterol in elderly patients with reversible obstructive airways disease. Respir. Med. 92(3), 562-567 (1998). (Pubitemid 28162172)
167. van Schayck CP, Folgering H, Harbers H, Maas KL, van Weel C: Effects of allergy and age on responses to salbutamol and ipratropium bromide in moderate asthma and chronic bronchitis. Thorax 46(5), 355-359 (1991).
168. Kradjan WA, Driesner NK, Abuan TH, Emmick G, Schoene RB: Effect of age on bronchodilator response. Chest 101(6), 1545-1551 (1992).
169. Nishimura K, Koyama H, Ishihara K et al.: Additive effect of oxitropium bromide in combination with inhaled corticosteroids in the treatment of elderly patients with chronic asthma. Allergol. Intern. 48(1), 85-88 (1999).
170. Kesten S, Jara M, Wentworth C, Lanes S: Pooled clinical trial analysis of tiotropium safety. Chest 130(6), 1695-1703 (2006).
171. Kalra L, Bone MF: The effect of nebulized bronchodilator therapy on intraocular pressures in patients with glaucoma. Chest 93(4), 739-741 (1988).
172. Ohnishi A, Kato M, Kojima J, Ushiama H, Yoneko M, Kawai H: Differential pharmacokinetics of theophylline in elderly patients. Drugs Aging 20(1), 71-84 (2003).
173. Shannon M, Lovejoy FH Jr: The influence of age vs peak serum concentration on life-threatening events after chronic theophylline intoxication. Arch. Intern. Med. 150(10), 2045-2048 (1990).
174. Haahtela T, Tuomisto LE, Pietinalho A et al.: A 10 year asthma programme in Finland: major change for the better. Thorax 61(8), 663-670 (2006).
175. Bellia V, Pistelli F, Giannini D et al.: Questionnaires, spirometry and PEF monitoring in epidemiological studies on elderly respiratory patients. Eur. Respir. J. Suppl. 40, 21s-27s (2003).